Psyence Group Past Earnings Performance
Past criteria checks 0/6
Psyence Group has been growing earnings at an average annual rate of 44.4%, while the Biotechs industry saw earnings growing at 15% annually.
Key information
44.4%
Earnings growth rate
18.4%
EPS growth rate
| Biotechs Industry Growth | 17.0% |
| Revenue growth rate | n/a |
| Return on equity | -922.3% |
| Net Margin | n/a |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Psyence Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 0 | -5 | 3 | 3 |
| 30 Sep 23 | 0 | -7 | 3 | 3 |
| 30 Jun 23 | 0 | -7 | 4 | 3 |
| 31 Mar 23 | 0 | -6 | 4 | 2 |
| 31 Dec 22 | 0 | -4 | 4 | 1 |
| 30 Sep 22 | 0 | -4 | 4 | 0 |
| 30 Jun 22 | 0 | -5 | 4 | 0 |
| 31 Mar 22 | 0 | -5 | 4 | 0 |
| 31 Dec 21 | 0 | -15 | 5 | 0 |
| 30 Sep 21 | 0 | -15 | 6 | 0 |
| 30 Jun 21 | 0 | -15 | 5 | 0 |
Quality Earnings: PSYG.F is currently unprofitable.
Growing Profit Margin: PSYG.F is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if PSYG.F's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare PSYG.F's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: PSYG.F is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-14.4%).
Return on Equity
High ROE: PSYG.F has a negative Return on Equity (-922.3%), as it is currently unprofitable.